Close Menu

The Washington Post's Christopher Weaver says that, "over the past two decades, venture capitalists helped make possible striking advances in health care, including robotic surgery, cancer vaccines, and genomics." But US healthcare spending is "forecasted to grow in an unaffordable way for the country," says John Doerr from Kleiner Perkins Caufield & Byers -- a situation making more VCs focus on supporting companies that could help cut those costs, according to Weaver.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.